Lactose (India) Ltd (LACTOSE) — shareholding pattern, promoter holding, financials and share price
About Lactose (India) Ltd (LACTOSE)
Lactose (India) Ltd operates in the Pharmaceuticals industry, within the Healthcare sector. It trades on the NSE as LACTOSE and on the BSE under scrip code 524202. Its ISIN is INE058I01013.
Incorporated in 1991, Lactose (India) Ltd manufactures Pharmaceutical Products and carries out job work [1]
Lactose (India) Ltd is a manufacturing and trading company in the pharmaceutical sector, specializing in edible and pharmaceutical-grade lactose alongside dairy products.
The company has undertaken significant expansions, increasing lactose production capacity substantially from 465 tpa to 1500 tpa within a few years.
Listed peers in Pharmaceuticals: Smruthi Organics Ltd, Bal Pharma Ltd, Tyche Industries Ltd, Godavari Drugs Ltd, Pharmaids Pharmaceuticals Ltd, Krebs Biochemicals & Industries Ltd.
Valuation & Returns
10 Jul 2026At ₹100 a share on 10 Jul 2026, Lactose (India) Ltd (LACTOSE) was valued at a price-to-earnings ratio of 20.74x against an industry P/E of 36.41x and a price-to-book of 2.14x on a book value of ₹46.66 per share as of Mar 2025. Solomo computes return on equity of 10.33% and return on capital employed of 11.85% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 20.74x
- Industry P/E
- 36.41x
- P/B
- 2.14x
- EPS (TTM)
- ₹4.82
- Book value / share
- ₹46.66
- ROE
- 10.33%
- ROCE
- 11.85%
- ROA
- 4.55%
- Debt / equity
- 0.97x
- Dividend yield
- 0%
- EBITDA margin
- 11.91%
- 52-week range
- ₹76.01 – ₹136.7
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Lactose (India) Ltd (LACTOSE) reported revenue of ₹163 crore, net profit of ₹6 crore and earnings per share of ₹4.81. That compares with revenue of ₹116 crore and net profit of ₹5 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹45.77 crore and net profit ₹1.88 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 46 | 66 | 114 | 116 | 163 |
| Net profit (₹ cr) | 2 | 1 | 7 | 5 | 6 |
| EPS (₹) | 1.95 | 0.96 | 5.39 | 4.1 | 4.81 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 14.24% | 23.79% | 36.33% | 2.20% |
| Profit growth | 7.02% | 135.02% | 28.18% | -24.01% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 53.65% of Lactose (India) Ltd (LACTOSE) (unchanged from the previous quarter) and domestic institutional investors (DII) hold 0.62%. Promoters have pledged 26.1% of their holding. Market capitalisation was ₹126 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2003.
Largest disclosed public shareholders in Jun 2026: MADHUSHA HOLDINGS PRIVATE LIMITED 3.99%, JAIKAAY TRADEVENTURE PRIVATE LIMITED 1.04%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 53.65% | 26.1% | - | 0.62% | 46.35% |
| Mar 2026 | 53.65% | 26.1% | - | 0.62% | 46.35% |
| Dec 2025 | 53.65% | 26.1% | - | 0.62% | 46.35% |
| Sep 2025 | 53.65% | 26.1% | - | 0.62% | 46.35% |
| Jun 2025 | 53.65% | 26.1% | - | 0.62% | 46.35% |
| Mar 2025 | 53.65% | 26.1% | - | 0.62% | 46.35% |
| Dec 2024 | 53.65% | 26.1% | - | 0.62% | 46.35% |
| Sep 2024 | 53.65% | 26.1% | - | 0.62% | 46.35% |